A recent groundbreaking study spearheaded by Dr. Tracy Crane, Ph.D., RDN, co-leader of the Cancer Control Program at the Sylvester Comprehensive Cancer Center and University of Miami Miller School of Medicine, has demonstrated the profound benefits of remote perioperative monitoring (RPM) in enhancing postoperative recovery for cancer patients. This investigation, published in the prestigious journal npj Digital Medicine, focused on patients undergoing major abdominal or pelvic surgeries for a range of gastrointestinal, genitourinary, and gynecologic cancers, offering new insights into the convergence of digital health and surgical oncology.
The randomized controlled trial included 293 patients, comparing conventional surgeon-led postoperative care with an innovative RPM approach. Patients in the RPM arm were equipped with wristband accelerometers and utilized a mobile application to report symptoms both prior to surgery and at scheduled intervals following hospital discharge. This digital framework enabled continuous collection of real-world data streams, dynamically informing the clinical team about each patient’s functional status and symptom burden. When sensor readings or patient-reported information crossed predefined thresholds, triage nurses initiated timely interventions through direct contact, thereby bridging the gap between hospital-based care and home recovery.
Data from this analysis revealed a statistically significant increase in functional recovery rates by postoperative day 14 among those receiving RPM care, with a 6% improvement compared to controls. Moreover, patients monitored remotely experienced fewer major complications, underscoring the potential of telemonitoring to identify early warning signs and avert adverse outcomes. Beyond these clinical endpoints, participants also reported superior symptom management and diminished interference of symptoms with daily activities, illustrating both objective and subjective benefits of incorporating digital tools into postoperative protocols.
Dr. Crane, who directs lifestyle medicine, prevention, and digital health initiatives at Sylvester, emphasized the critical nature of the immediate post-discharge period. “The first two weeks after leaving the hospital represent a vulnerable phase where many complications arise unnoticed,” she explained. “Our remote monitoring strategy functions as a safety net that captures early deviations, facilitates rapid responses, and ultimately promotes a smoother trajectory of recovery.”
One of the distinguishing features of this study is its reliance on patient-reported outcomes alongside digital biomarkers, including activity levels captured by wearable technology. This dual approach equips clinicians with a richer, more nuanced understanding of recovery dynamics that transcends traditional postoperative assessments, which often depend on episodic clinical visits and subjective recollections. Additionally, the study’s inclusion of both English and Spanish-speaking patients reflects an intentional effort to verify the feasibility and applicability of RPM solutions across diverse populations using their personal devices.
Integral to Dr. Crane’s vision is the seamless integration of these digital health innovations into routine oncological care. The My Wellness Research platform, developed under her leadership, exemplifies this goal by aggregating patient-generated data such as nutrition logs, physical activity metrics, and wearable sensor outputs. This platform harmonizes such data with clinical, genomic, imaging, and sociodemographic information, generating a multidimensional cancer data ecosystem. Its dynamic interface permits real-time communication among patients, health coaches, and healthcare providers—an infrastructure that not only enables remote monitoring but also supports personalized treatment planning and adaptive lifestyle interventions.
Crane’s work elucidates the critical interplay between technology and human expertise. While the digital tools provide continuous streams of valuable data, it is the responsiveness and clinical acumen of healthcare professionals that translate these signals into meaningful interventions. “Technology alone is insufficient,” Crane remarked. “The essence lies in leveraging computational methods to augment, not replace, human judgment. We need to discern when to rely on algorithms and when to engage the human touch.”
This research builds upon more than a decade of Crane’s commitment to harnessing digital innovation in oncology. Her earlier involvement in the LIVES study—a non-pharmacologic ovarian cancer trial encompassing over 1,200 participants across 100 cancer centers—pioneered the use of cloud-based recording systems to capture telephone intervention sessions for fidelity monitoring and study management. These audio datasets unveiled hidden behavioral patterns, propelling subsequent projects funded by the National Cancer Institute to develop natural language processing models capable of analyzing conversations to predict coaching needs and refine training methods.
At Sylvester, the My Wellness Research platform now incorporates such advanced analytic tools to monitor protocol adherence and decode patient-specific language nuances related to symptoms and psychosocial factors. When combined with wearable data from devices like Fitbit, the platform facilitates the tailoring of lifestyle and therapeutic interventions—marking a pivotal transition from one-size-fits-all care to precision oncology anchored in personalized health profiles.
Beyond the immediate benefits of RPM, Crane leads a portfolio of complementary studies designed to elucidate the impact of lifestyle modifications on cancer outcomes. These include investigations into personalized nutrition interventions for ovarian cancer patients funded by the National Cancer Institute, as well as clinical trials examining how diet and physical activity may mitigate recurrence risk in survivors of breast, prostate, and colorectal cancers. Collaborative efforts with Sylvester’s survivorship program further aim to develop digital tools that foster sustainable behavioral change and enhance quality of life post-treatment.
Dr. Crane’s interdisciplinary research reflects a paradigm shift in oncology—from a sole focus on tumor biology and surgery to a holistic understanding that integrates lifestyle behaviors, digital health, and patient-centered approaches. This vision encapsulates a future where technological innovation is harmonized with humanistic care to optimize outcomes across the continuum of cancer treatment and survivorship.
As digital health technologies continue to evolve rapidly, Dr. Crane advocates for widespread adoption of practices that empower healthcare providers to adeptly manage complex data streams. “Tomorrow’s providers must be fluent in interpreting information generated by connected devices and skilled in forging collaborative partnerships across disciplines,” she asserted. “Only by centering patients in every clinical decision and exploiting technology thoughtfully can we usher in the next era of cancer care.”
This study stands as a beacon for transforming perioperative care in oncology, demonstrating how remote telemonitoring can meaningfully enhance recovery, reduce complications, and elevate patient experiences. It highlights a scalable and unobtrusive model that can be adopted widely, signaling a future where digital medicine and human expertise coalesce seamlessly to improve the lives of cancer patients worldwide.
Subject of Research: Remote perioperative monitoring to improve recovery outcomes in cancer surgery patients
Article Title: Comparative effectiveness of remote perioperative telemonitoring in cancer surgery: a randomized trial
News Publication Date: 28-Aug-2025
Web References:
https://www.nature.com/articles/s41746-025-01961-z
References:
Funding and disclosures are detailed in the original study publication.
Image Credits:
Photo by Sylvester Comprehensive Cancer Center
Keywords:
Cancer research, Clinical studies, Personalized medicine, Clinical medicine, Surgery, Oncology, Biotechnology, Medical technology
